Categories: Business

Eevia Health Plc receives a 5,8 MSEK/0,55 MEUR sales order for high concentrate anthocyanin organic bilberry extract

Eevia Health Plc reported that it has received a sales order from its Australian distributor Ingredients Plus.

Ingredients Plus serves leading nutraceutical brands in Oceania and Asia with high-quality ingredients. The end customer is a major natural health company based out of Sydney, Australia selling its consumer products across Asia and Oceania.
The sales value of this order is c. 545 000 EUR. The product is Feno-Myrtillus® bilberry extract standardized with a minimum of 36% anthocyanins. The Feno-Myrtillus® powder is extracted from arctic bilberries. The bilberry anthocyanin is a polyphenol with great benefits to human health which is included in a range of applications in food and dietary supplements with multiple benefits for human health. The order is slightly higher than earlier expectations for repeat sales of this product and is confirmed subject to the sufficient availability of raw materials at a pre-calculated raw material price for the upcoming harvest.

 

With the volatility in the raw material markets due to the war in Ukraine, which is a large supplier of bilberries, and the continued pandemic, we are pleased to see that major brand organizations put their trust in Eevia Health as a reliable and high-quality supplier of berry extracts based on Swedish and Finnish bilberries,” says Anna-Maija Vanhatalo, Customer Service Manager in Eevia Health.

 

This disclosure contains information that EEVIA HEALTH PLC is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on June 27, 2022.

 

Jimmy Fraley

Recent Posts

GRUPO ELEKTRA ANNOUNCES REVENUE OF Ps.40,045 MILLION AND EBITDA OF Ps.4,119 MILLION IN THE THIRD QUARTER OF 2022

Grupo Elektra, S.A.B. de C.V. (BMV: ELEKTRA* Latibex: XEKT), Latin America's leading specialty retailer and financial services…

2 years ago

mCloud Announces Proposed Unsecured Loan from Strategic Investors

mCloud Technologies Corp. (Nasdaq: MCLD) (TSX-V: MCLD), ("mCloud" or the "Company") a leading provider of AI-powered asset…

2 years ago

TransPerfect Acquires Sterling Technology

TransPerfect, the world's largest provider of language and technology solutions for global business, announced that…

2 years ago

Comerica Incorporated Names Kelly Gage, Director of Investor Relations; Darlene Persons to Retire on April 1

Comerica Incorporated (NYSE: CMA) announced that Kelly Gage, National Director of Sales and Strategy for the Commercial Bank…

2 years ago

Genomadix Inc. Announces Know-How License Agreement with Mayo Clinic

Genomadix announced it has entered into a know-how license agreement and stock purchase agreement with…

2 years ago

ASLAN Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update

ASLAN Pharmaceuticals (Nasdaq: ASLN), a clinical-stage, immunology-focused biopharmaceutical company developing innovative treatments to transform the…

2 years ago

This website uses cookies.